No profile data available.
Biomerica, Inc. (BMRA) is a healthcare company in the additional medical testing equipment industry, based in Irvine, United States, with about 50 full-time employees.
It reported revenue of $5.31 million for fiscal year 2025, down 1.9% from fiscal year 2024, and net income of -$4.97 million. In Q3 2026 (the quarter ended February 28, 2026) revenue was $987,000, down 11.8% from a year before. Asia was its largest region in fiscal year 2025, with 32% of revenue. Its market capitalization was $8.44 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended May 31, 2025; market data as of October 9, 2026.
, a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America.
Biomerica reported $5.31 million in revenue for fiscal year 2025, down 1.9% from $5.42 million in fiscal year 2024. In Q3 2026 revenue was $987,000.
Asia: 32% of revenue by region in fiscal year 2025, followed by North America (31%).
$8.44 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include QuidelOrtho Corporation (QDEL), Exagen Inc. (XGN), Global Cord Blood Corporation (CORBF), QHSLab, Inc. (USAQ).